Allogene Therapeutics Inc(ALLO-Q)NASDAQ
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr06/2024 | Next Qtr09/2024 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | -0.35 | -0.36 | -1.50 | -1.58 |
| Number of Estimates | 12 | 11 | 12 | 12 |
| High Estimate | -0.28 | -0.32 | -1.33 | -1.21 |
| Low Estimate | -0.39 | -0.41 | -1.70 | -2.02 |
| Prior Year | -0.53 | -0.37 | -2.01 | -1.50 |
| Growth Rate Est. (year over year) | +33.96% | +2.70% | +25.37% | -5.33% |
Earnings History - Surprises*
| Qtr Ending03/2024 | Qtr Ending12/2023 | Qtr Ending09/2023 | Qtr Ending06/2023 | |
|---|---|---|---|---|
| Reported | $-0.38 | $-0.43 | $-0.37 | $-0.53 |
| Estimate | $-0.38 | $-0.47 | $-0.53 | $-0.59 |
| Difference | unch | +0.04 | +0.16 | +0.06 |
| Surprise | unch | +8.51% | +30.19% | +10.17% |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.39
3 Mths Ago18
4.39
2 Mths Ago18
4.39
1 Mth Ago18
4.42
Current19
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 18 | 18 | 18 | 19 |
12 1 | 12 1 | 12 1 | 13 1 | |
| Holds | 5 | 5 | 5 | 5 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell